Diary News and Research

RSS

Lifestyle interventions can help pediatricians meet the growing need for youth depression management

With rising prevalence of depression in adolescents, screening requirements are increasingly falling on pediatric primary care providers, who are encountering more at-risk patients.

15 Sep 2022

Phase 3 clinical trial commences to evaluate antiviral for monkeypox

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States.

9 Sep 2022

AbbVie to present data from its robust migraine portfolio at the Migraine Trust International Symposium 2022

AbbVie today announced that new data from its migraine portfolio will be presented at the Migraine Trust International Symposium (MTIS) 2022, taking place in London from September 8-11.

From AbbVie 8 Sep 2022

Study shows how feasible reductions in ultra-processed food consumption positively impact the nutritional quality of diets

Researchers assessed the association between consumption of ultra-processed food and dietary nutrient profiles.

8 Sep 2022

AI model detects COVID-19 infection in people’s voices

Artificial intelligence (AI) can be used to detect COVID-19 infection in people's voices by means of a mobile phone app, according to research to be presented on Monday at the European Respiratory Society International Congress in Barcelona, Spain.

5 Sep 2022

$Women on vegetarian diet have higher risk of hip fracture compared to regular meat-eaters$

Women on vegetarian diet have higher risk of hip fracture compared to regular meat-eaters

A study of over 26,000 middle-aged UK women reveals those with a vegetarian diet had a 33% higher risk of hip fracture compared to regular meat-eaters.

11 Aug 2022

What is the viral rebound in untreated COVID-19 infections?

Researchers assessed the coronavirus disease 2019 (COVID-19) rebound in untreated COVID-19 infections.

4 Aug 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 21 Jul 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application to the European Medicines Agency for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 19 Jul 2022

Light exposure at night linked to obesity, hypertension and diabetes among older adults

In a sample of older men and women ages 63 to 84, those who were exposed to any amount of light while sleeping at night were significantly more likely to be obese, and have high blood pressure and diabetes compared to adults who were not exposed to any light during the night, reports a new Northwestern Medicine study.

22 Jun 2022

Stresses of the COVID-19 pandemic led to disturbed ovulation, finds study

Life disruptions and the stresses of the COVID-19 pandemic led to disturbed ovulation with decreased progesterone durations or levels, according to research being presented Sunday at ENDO 2022, the Endocrine Society's annual meeting in Atlanta, Ga.

13 Jun 2022

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

A recent phase 1/2 study under review at the Nature Portfolio journal and posted to the Research Square* preprint server demonstrated that a peptide-centered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) T-cell activator, CoVac-1, was efficient in B-cell deficient people.

6 Jun 2022

Nurse-led program helped Black and Hispanic people in Bronx better manage blood pressure

A nurse-led blood pressure program that included patient education and support for management of high blood pressure resulted in participants taking their blood pressure medication regularly and having fewer episodes of uncontrolled high blood pressure, according to preliminary research to be presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2022.

15 May 2022

New COVID Recovery Clinic launched by Keck Medicine of USC

Keck Medicine of USC has launched its COVID Recovery Clinic, a multidisciplinary program led by a core team of clinicians specializing in primary care, pulmonology and physical therapy.

29 Mar 2022

Financial rewards can be a key motivator for achieving weight loss

With two in three Australian adults currently overweight or obese, and about 47 per cent of Australians now living with related chronic health conditions, an updated report from Australia’s national science agency, CSIRO, has reinforced that personal accountability coupled with financial rewards continue to be a key motivator for achieving weight loss.

16 Mar 2022

Supportive friendships between colleagues could unlock creative thinking at work, study shows

Employers who want to see creative thinking in their workforce should value supportive friendships between colleagues as the key to unlocking more resourcefulness and innovation.

18 Feb 2022

Treatment found to be safe, efficacious in improving insomnia and night sweats among midlife women

Hot flashes and night sweats are a common cause of insomnia among peri- and postmenopausal women. Hot flashes, night sweats and insomnia are all linked to reduced quality of life and distress.

17 Feb 2022

Eligible adults urged to take part in world-first COVID-19 study of antivirals

Adults over the age of 50 or with an underlying health condition who test positive for COVID-19 are being urged to sign up for a world-first COVID-19 study which is providing life-saving antivirals to thousands of people.

24 Jan 2022

Researchers call for more work to address unmet needs of women with Parkinson's disease

Researchers in a multi-institution study led by UCLA Health have identified several overlooked issues affecting women with Parkinson's Disease (PD) and call for more research, customized treatments, education and support to empower women living with this disease and to address their unmet medical needs.

22 Jan 2022

Echinacea as a potential force against coronavirus infections

A new review identified clinical studies evaluating coronavirus infections in the context of Echinacea administration and assessed preventive and therapy advantages against COVID-19.

21 Jan 2022

Diary News and Research

Lifestyle interventions can help pediatricians meet the growing need for youth depression management

Phase 3 clinical trial commences to evaluate antiviral for monkeypox

AbbVie to present data from its robust migraine portfolio at the Migraine Trust International Symposium 2022

Study shows how feasible reductions in ultra-processed food consumption positively impact the nutritional quality of diets

AI model detects COVID-19 infection in people’s voices

Women on vegetarian diet have higher risk of hip fracture compared to regular meat-eaters

What is the viral rebound in untreated COVID-19 infections?

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Light exposure at night linked to obesity, hypertension and diabetes among older adults

Stresses of the COVID-19 pandemic led to disturbed ovulation, finds study

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

Nurse-led program helped Black and Hispanic people in Bronx better manage blood pressure

New COVID Recovery Clinic launched by Keck Medicine of USC

Financial rewards can be a key motivator for achieving weight loss

Supportive friendships between colleagues could unlock creative thinking at work, study shows

Treatment found to be safe, efficacious in improving insomnia and night sweats among midlife women

Eligible adults urged to take part in world-first COVID-19 study of antivirals

Researchers call for more work to address unmet needs of women with Parkinson's disease

Echinacea as a potential force against coronavirus infections

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News